Participant flow36

How many started, completed or left each group, period by period.

1 to 20 of 36

Period	Milestone	Group	Participants
Overall Study	STARTED	ESL 1200 mg QD	85
Overall Study	STARTED	ESL 400 mg BD	89
Overall Study	STARTED	ESL 600 mg BID	95
Overall Study	STARTED	ESL 800 mg BID	100
Overall Study	STARTED	ESL 800 mg QD	92
Overall Study	STARTED	Placebo	96
Overall Study	Randomized	ESL 1200 mg QD	85
Overall Study	Randomized	ESL 400 mg BD	89
Overall Study	Randomized	ESL 600 mg BID	95
Overall Study	Randomized	ESL 800 mg BID	100
Overall Study	Randomized	ESL 800 mg QD	92
Overall Study	Randomized	Placebo	96
Overall Study	Safety Population	ESL 1200 mg QD	85
Overall Study	Safety Population	ESL 400 mg BD	89
Overall Study	Safety Population	ESL 600 mg BID	95
Overall Study	Safety Population	ESL 800 mg BID	100
Overall Study	Safety Population	ESL 800 mg QD	92
Overall Study	Safety Population	Placebo	96
Overall Study	Per-protocol	ESL 1200 mg QD	55
Overall Study	Per-protocol	ESL 400 mg BD	66

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00980746/flow